The Impact of CRISPR-Cas System on Antiviral Therapy
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II of this system, CRISPR-Cas9, is the most versatile form that has enabled facile and efficient targeted genome editing. Vira...
Saved in:
Main Authors: | Hadi Bayat (Author), Fatemeh Naderi (Author), Amjad Hayat Khan (Author), Arash Memarnejadian (Author), Azam Rahimpour (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of CRISPR-Cas system for clinical cancer therapy
by: Xiang Meng, et al.
Published: (2023) -
CRISPR/Cas9 RET Gene Knockout in Medullary Thyroid Carcinoma Cell-lines: Optimization and Validation
by: Marjan Zarif-Yeganeh, et al.
Published: (2022) -
CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
by: Muhammad Uzair Javed, et al.
Published: (2023) -
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023) -
Bioinformatics investigation of CRISPR/Cas systems in Bifidobacterium longum
by: Amir Zarrinhaghighi, et al.
Published: (2021)